Jiangsu Biojetay Biotechnology Co., Ltd.
Clinical trials sponsored by Jiangsu Biojetay Biotechnology Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for hemophilia patients with inhibitors: STSP-0601 enters phase 3 trial Results expected Sep 2026 (estimated)
- New injection aims to boost platelets in ITP patients Results expected Sep 2026 (estimated)